DK0874645T3 - Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik - Google Patents

Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik

Info

Publication number
DK0874645T3
DK0874645T3 DK97902179T DK97902179T DK0874645T3 DK 0874645 T3 DK0874645 T3 DK 0874645T3 DK 97902179 T DK97902179 T DK 97902179T DK 97902179 T DK97902179 T DK 97902179T DK 0874645 T3 DK0874645 T3 DK 0874645T3
Authority
DK
Denmark
Prior art keywords
metal complexes
perflouralkyl
containing metal
nmr diagnostics
agents
Prior art date
Application number
DK97902179T
Other languages
Danish (da)
English (en)
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduechel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Thomas Frenzel
Bernd Misselwitz
Wolfgang Ebert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0874645T3 publication Critical patent/DK0874645T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/14—Linings or internal coatings
    • B65D25/16—Loose, or loosely-attached, linings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00—Closures with filling and discharging, or with discharging, devices
    • B65D47/04—Closures with discharging devices other than pumps
    • B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
    • B65D47/08—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures
    • B65D47/0804—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage
    • B65D47/0833—Hinges without elastic bias
    • B65D47/0847—Hinges without elastic bias located within a flat surface of the base element
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/771—Containers or packages with special means for dispensing contents for dispensing fluent contents by means of a flexible bag or a deformable membrane or diaphragm
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97902179T 1996-01-19 1997-01-16 Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik DK0874645T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19603033A DE19603033A1 (de) 1996-01-19 1996-01-19 Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
PCT/EP1997/000209 WO1997026017A2 (de) 1996-01-19 1997-01-16 Perfluoralkylhaltige metallkomplexe und ihre verwendung in der nmr-diagnostik

Publications (1)

Publication Number Publication Date
DK0874645T3 true DK0874645T3 (da) 2002-07-01

Family

ID=7783921

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902179T DK0874645T3 (da) 1996-01-19 1997-01-16 Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik

Country Status (27)

Country Link
US (3) US6468502B1 (pl)
EP (1) EP0874645B1 (pl)
JP (1) JP2000506511A (pl)
KR (1) KR100539041B1 (pl)
CN (1) CN1203898C (pl)
AT (1) ATE215386T1 (pl)
AU (1) AU716788B2 (pl)
BG (1) BG62914B1 (pl)
BR (1) BR9707053B1 (pl)
CZ (1) CZ298769B6 (pl)
DE (2) DE19603033A1 (pl)
DK (1) DK0874645T3 (pl)
EE (1) EE04298B1 (pl)
ES (1) ES2174215T3 (pl)
HU (1) HU226199B1 (pl)
IL (1) IL125311A (pl)
IS (1) IS2127B (pl)
NO (1) NO319680B1 (pl)
NZ (1) NZ330579A (pl)
PL (1) PL187466B1 (pl)
PT (1) PT874645E (pl)
RU (1) RU2242477C2 (pl)
SK (1) SK283576B6 (pl)
TW (1) TW542841B (pl)
UA (1) UA65533C2 (pl)
WO (1) WO1997026017A2 (pl)
ZA (1) ZA97419B (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6495118B1 (en) * 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
EP1088559A3 (de) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenische Formulierungen
DE19948650A1 (de) * 1999-09-29 2001-07-19 Diagnostikforschung Inst Galenische Formulierungen
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040380B4 (de) * 2000-08-11 2006-03-09 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
JP2005501082A (ja) * 2001-08-03 2005-01-13 グラクソ　グループ　リミテッド 界面活性剤化合物およびその使用
NO20015814D0 (no) * 2001-11-28 2001-11-28 Amersham Health As Metallkompleksforbindelser
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
AU2003249999A1 (en) * 2002-07-10 2004-02-02 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
SI1836239T1 (sl) 2005-01-13 2009-04-30 Cinv Ag Kompozitni materiali, ki vsebujejo ogljikove nanodelce
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
DE102005033902B3 (de) * 2005-07-15 2007-04-05 Schering Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033903B4 (de) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
RU2308290C1 (ru) * 2006-03-10 2007-10-20 Общество с ограниченной ответственностью "ЛЧЗ" Магнитно-резонансная и рентгеновская контрастная композиция
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
RU2446829C2 (ru) * 2006-06-09 2012-04-10 Конинклейке Филипс Электроникс Н.В. Устранение зависимости от концентрации контрастного агента в мрт
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
GB0708411D0 (en) * 2007-05-01 2007-06-06 Univ Durham Lanthanide probes
RU2391347C1 (ru) * 2008-10-23 2010-06-10 Государственное образовательное учреждение высшего профессионального образования "Казанский государственный университет им. В.И. Ульянова-Ленина" Высокорелаксивные комплексы гадолиния
US20110217241A1 (en) * 2008-11-14 2011-09-08 University Of Maryland, Baltimore Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
US20170369755A1 (en) * 2014-12-08 2017-12-28 3M Innovative Properties Company Hydrofluoroolefins and methods for using same
HUP1500076A2 (hu) * 2015-02-25 2016-09-28 Debreceni Egyetem Új helyettesített etilén-diamin-tetraecetsav-bisz(amid) származékok és alkalmazásuk Mn(II)-alapú MRI kontrasztanyag ligandumként
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
JP7523883B2 (ja) 2015-08-13 2024-07-29 ザ ジェネラル ホスピタル コーポレイション 分子ｍｒイメージング用マンガン系キレートコンジュゲート
EP3544964B1 (en) 2016-11-28 2020-06-17 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
IL321215B2 (en) 2018-11-23 2026-05-01 Bayer Ag Contrast media formulation and process for its preparation
US20200397924A1 (en) * 2019-01-28 2020-12-24 Hubei Tianshu Pharmaceutical Co., Ltd Preparation method of intermediate of gadolinium-based ionic contrast agent and use thereof
EP4047356A4 (en) * 2019-10-17 2023-11-22 Riken DETECTION METHOD AND SYSTEM FOR DETECTION OF MASTITIS IN A DOMESTIC ANIMAL
JP7727550B2 (ja) * 2019-11-26 2025-08-21 東ソー・ファインケム株式会社 含フッ素アニオン性界面活性剤
CN110922365B (zh) * 2019-12-13 2021-04-27 山东铂源药业有限公司 一种高纯度轮环藤宁的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762701A (en) 1986-10-31 1988-08-09 Smithkline Beckman Corporation In vivo cellular tracking
US4859584A (en) 1986-10-31 1989-08-22 Smithkline Beckman Corporation Cell growth rate determination by measurement of changes in cyanine dye levels in plasma membranes
US5672334A (en) 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
DE440606T1 (de) * 1987-12-24 1992-02-27 Bracco Industria Chimica S.P.A., Mailand / Milano Macrocyclische chelatisierungsmittel und daraus hergestellte chelate.
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE3930674A1 (de) 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
JPH06181890A (ja) * 1992-10-06 1994-07-05 Terumo Corp Ｍｒｉ造影剤
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
US6461587B1 (en) * 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
EP1088559A3 (de) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenische Formulierungen
US6676928B2 (en) * 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
US6641797B2 (en) * 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses

Also Published As

Publication number Publication date
BR9707053B1 (pt) 2008-11-18
NO983287D0 (no) 1998-07-16
US6916461B2 (en) 2005-07-12
WO1997026017A2 (de) 1997-07-24
HUP9901295A2 (hu) 1999-07-28
BG102632A (bg) 1999-06-30
ES2174215T3 (es) 2002-11-01
IS4790A (is) 1998-06-30
US7226578B2 (en) 2007-06-05
ZA97419B (en) 1997-07-30
EP0874645B1 (de) 2002-04-03
IL125311A0 (en) 1999-03-12
PT874645E (pt) 2002-09-30
UA65533C2 (en) 2004-04-15
PL187466B1 (pl) 2004-07-30
CN1209754A (zh) 1999-03-03
BG62914B1 (bg) 2000-11-30
CZ226398A3 (cs) 1998-11-11
US6468502B1 (en) 2002-10-22
US20030232012A1 (en) 2003-12-18
BR9707053A (pt) 1999-07-20
EE9800204A (et) 1998-12-15
ATE215386T1 (de) 2002-04-15
NO319680B1 (no) 2005-09-05
SK283576B6 (sk) 2003-09-11
TW542841B (en) 2003-07-21
EP0874645A2 (de) 1998-11-04
PL327931A1 (en) 1999-01-04
CZ298769B6 (cs) 2008-01-23
CN1203898C (zh) 2005-06-01
NZ330579A (en) 2000-01-28
NO983287L (no) 1998-09-21
KR19990077374A (ko) 1999-10-25
IL125311A (en) 2002-11-10
HK1018404A1 (en) 1999-12-24
IS2127B (is) 2006-07-14
JP2000506511A (ja) 2000-05-30
RU2242477C2 (ru) 2004-12-20
EE04298B1 (et) 2004-06-15
WO1997026017A3 (de) 1997-11-20
DE19603033A1 (de) 1997-07-24
AU716788B2 (en) 2000-03-09
US20050147563A1 (en) 2005-07-07
HU226199B1 (en) 2008-06-30
AU1597797A (en) 1997-08-11
KR100539041B1 (ko) 2006-04-12
SK99098A3 (en) 1998-12-02
HUP9901295A3 (en) 2004-05-28
DE59706863D1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
NO983287D0 (no) Perfluorholdige metallkomplekser, fremgangsmate for fremstilling av slike og deres anvendelse ved NMR-diagnostikk
NO954440L (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
SG46496A1 (en) Tricyclopolyazamacrocyclophosphonic acids complexes and derivatives thereof for use as constrast agents
DE60001564D1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
DE3577185D1 (de) Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
ZA965686B (en) Cascade polymer complexes process for their production and pharmaceutical agents containing said complexes
DE69014074D1 (de) Röntgenraster für medizinische röntgenaufnahmen und verfahren zu dessen herstellung und zu dessen verwendung.
EA200001169A1 (ru) Специфично связывающиеся молекулы для сцинтиграфии, содержащие их конъюгаты и терапевтический способ лечения ангиогенеза
NO173429C (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for NMR-avbildning
HUP0103758A2 (hu) Neurotróf faktorok
WO2001087354A3 (en) Use of small molecule radioligands for diagnostic imaging
NO903597L (no) Fysiologisk forenlige amid-kompleksforbindelser og deres anvendelse ved fremstilling av midler for organspesifikk nmr-diagnostikk.
DE69425820D1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DK0570575T3 (da) Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf
IL114858A0 (en) DTPA derivatives metal complexes thereof pharmaceutical and diagnostic agents containing the same and methods for the preparation thereof
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
CA2243316A1 (en) Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis
GR1005061B (el) Πρωτεινες με προγνωστικη, διαγνωστικη και θεραπευτικη σημασια για την τρισωμια 21 (συνδρομο down)
MY113423A (en) Substituted thiophenesulfonylureas and -thioureas processes for their preparation, their use as amedicament or diagnostic, and medicament contiaining them
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie
RU96114151A (ru) Способ диагностики хеликобактериоза